Michael North

Title: Michael North: Innovator in Neurosensory Genetics

Introduction

Michael North is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of genetics, particularly in understanding neurosensory defects and asthma-related genes. With a total of 6 patents, his work has implications for both therapeutic and diagnostic applications.

Latest Patents

One of Michael North's latest patents focuses on a gene family associated with neurosensory defects. This patent provides nucleic acid compositions that encode a family of mammalian proteins expressed in the retina and brain. Members of this gene family are genetically linked to various neurosensory defects, including cochlear degeneration, peripheral retinal degeneration, and cone-rod retinal dystrophy. The nucleic acid compositions are useful for identifying DNA sequences encoding homologous or related proteins, producing the encoded protein, and studying associated physiological pathways. Additionally, modulation of gene activity in vivo is utilized for prophylactic and therapeutic purposes, such as treating neurosensory defects and identifying retinal cells based on expression. The DNA is also used as a diagnostic tool for genetic predisposition to linked neurosensory defects.

Another significant patent identifies a genetic locus associated with asthma. Within this locus, the genes ASTH1I and ASTH1J, along with their regulatory sequences, are characterized. These genes are employed to produce the encoded proteins, screen for compositions that modulate the expression or function of ASTH1 proteins, and study associated physiological pathways. Furthermore, the DNA serves as a diagnostic for genetic predisposition to asthma.

Career Highlights

Michael North has worked with notable companies such as Sequana Therapeutics, Inc. and The Jackson Laboratory. His experience in these organizations has allowed him to advance his research and contribute to the field of genetics significantly.

Collaborations

Some of his notable coworkers include Patsy M. Nishina and Juergen K. Naggert. Their collaborations have likely enriched the research environment and fostered innovative solutions in genetics.

Conclusion

Michael North's work in genetics, particularly concerning neurosensory defects and asthma, showcases his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving diagnostic and therapeutic strategies in these critical areas.